ALK and mature T-cell and NK-cell non-Hodgkin lymphoma: A report involving 1,314 patients with PTCL and NK/TCL showed that the 5-year OS was 70% for ALK-positive ALCL and 32% for PTCL-NOS, angioimmunoblastic, and NK/TCL (10).